Day: August 7, 2021

Core One Labs to Move Its Psychedelic Formulations for the Treatment of Stroke and Depression Toward Clinical Development

Core One Labs to Move Its Psychedelic Formulations for the Treatment of Stroke and Depression Toward Clinical Development

Written by Customer Service on . Posted in Public Companies.

VANCOUVER, British Columbia, Aug. 07, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or the “Company”) is pleased to announce that the scientific team of its wholly owned subsidiary Akome Biotech Ltd. (“Akome”) has initiated the next step in their clinical development designs for the use of their patent pending psychedelic formulations AKO001 and AKO003, in the treatment of ischemic stroke and depression, respectively. These studies will further enhance the Company’s knowledge supporting the use of psychedelics as strong candidates in the treatment of these serious neurological and mental health conditions. As the next step in its clinical development design process, Akome is completing a comprehensive search and rigorous selection process, through which multiple...

Continue reading

ibex Provides Notice of Data Security Incident

ibex Provides Notice of Data Security Incident

Written by Customer Service on . Posted in Public Companies.

WASHINGTON, Aug. 07, 2021 (GLOBE NEWSWIRE) — ibex today issued this announcement concerning an earlier event, disclosed by the company on October 23, 2020 in its Annual Report (Form 20-F), which may have potentially impacted the security of information relating to certain employees and their families. While ibex is unaware of any attempted or actual misuse of personal information in relation to the event, ibex provided potentially affected individuals with notice, information about the event and steps individuals can take to help protect their information. On August 17, 2020, ibex learned that it was the victim of a malware attack that impacted the availability of a limited segment of our systems. We immediately took these systems offline and, with the assistance of third-party computer specialists, launched an investigation to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.